A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors
Coherent Biopharma (Hefei) Co., Ltd.
Coherent Biopharma (Hefei) Co., Ltd.
Minneamrita Therapeutics LLC
Lebanese University
Kineta Inc.
Genzada Pharmaceuticals USA, Inc.
Provectus Pharmaceuticals
Blue Note Therapeutics
Assistance Publique - Hôpitaux de Paris
Weprom
TScan Therapeutics, Inc.
University of Florence
SpeciCare
Petra Pharma
Universidad Complutense de Madrid
Proteus Digital Health, Inc.
The University of The West Indies
Xuanwu Hospital, Beijing
Qilu Pharmaceutical Co., Ltd.
Institut National de la Santé Et de la Recherche Médicale, France
National Cancer Center, Korea
Optimata Ltd.
SPGO Research Mannheim GmbH
The Cooper Health System
Chinese PLA General Hospital
Comprehensive Cancer Centers of Nevada
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
University of Aarhus
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Center, Korea
Rambam Health Care Campus
National Cancer Center, Korea